Herpes Simplex: all 302 studies
Page 3 of 4. Open to participants first (30), then studies with results posted, then the rest; newest registration first within each.
- NB-001 Treatment of Recurrent Herpes LabialisStatus unknownNCT01695187Phase 3
- Bioequivalence Study in Healthy Volunteers of a New Paediatric Formulation of ValacyclovirCompletedNCT01689285Phase 1
- Palatability Testing of a New Paediatric Formulation of ValacyclovirCompletedNCT01682109Phase 4
- Improving Blood Safety and HIV Testing in BrazilCompletedNCT01681420Not applicable
- Safety and Immunogenicity Study of Therapeutic HSV-2 VaccineCompletedNCT01667341Phase 1/2
- A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease)WithdrawnNCT01610765Phase 1/2
- Herpes Zoster Vaccine for Bone Marrow Transplant DonorsCompletedNCT01573182Phase 2
- Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in SpainCompletedNCT01521286
- Unusual Clinical Findings of Herpes EsophagitisStatus unknownNCT01501526
- Study of a Cold Sore Patch for the Treatment of Herpes LabialisCompletedNCT01484067Not applicable
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT01431326
- Interferon Responses in Eczema HerpeticumCompletedNCT01429311
- Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) InfectionCompletedNCT01386294Phase 3
- Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes ZosterCompletedNCT01327144Phase 3
- A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)CompletedNCT01324466Phase 3
- A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes LabialisCompletedNCT01321359Phase 3
- Non-inferiority Comparison of Efficacy and Safety of Penciclovir 10mg/g to Acyclovir 50mg/g in the Treatment of Recurrent Herpes LabialisCompletedNCT01257074Phase 3
- Study to Evaluate Using a Cold Sore Patch to Treat Herpes LabialisCompletedNCT01208298Not applicable
- Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?CompletedNCT01176409Phase 3
- Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella PertussisCompletedNCT01160081
- Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital HerpesCompletedNCT01154543
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting ConditionsCompletedNCT01132729Not applicable
- Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed ConditionsCompletedNCT01132716Not applicable
- Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2CompletedNCT01112956
- Safety and Immunogenicity of GSK Biologicals' Herpes Zoster Vaccine 1437173A in Healthy Ethnic Japanese AdultsCompletedNCT01086449Phase 1
- Effectiveness of TheraNeem Lip Therapy for Herpes Simplex LabialisCompletedNCT00985335Phase 1
- Prevalence of Sexually Transmitted Infections (STIs) in HIV-infected PatientsCompletedNCT00973466
- Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the CervixCompletedNCT00946556Not applicable
- Place Controlled Study to Treat Recurrent Herpes Labialis.CompletedNCT00914745Phase 2
- A Study of FV-100 Versus Valacyclovir in Patients With Herpes ZosterCompletedNCT00900783Phase 2
- Acupuncture in Herpes Zoster Neuralgia (ACUZoster)CompletedNCT00885586Phase 4
- Can Valacyclovir Delay the Need for Initiation of Human Immunodeficiency Virus (HIV) Treatment in HIV-infected Individuals?CompletedNCT00860977Phase 3
- A Phase 2b Trial of EPB-348 for the Treatment of Herpes ZosterCompletedNCT00831103Phase 2
- Efficacy of Acyclovir in Combination With a Glucocorticosteroid on UV-Induced Herpes LabialisCompletedNCT00736437Phase 2
- Study of ME-609 and Acyclovir for Treatment of Herpes Simplex Labialis in Immunocompromised PatientsCompletedNCT00735761Phase 3
- Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes DiseaseCompletedNCT00699764Phase 3
- Evaluation of Safety of Candidate gD Vaccine, With or Without MPL in Healthy Herpes Simplex Virus-positive AdultsCompletedNCT00698893Phase 1
- Safety Evaluation of Herpes Simplex Candidate Vaccine (gD2t) With Adjuvant in HSV Seropositive / Seronegative SubjectsCompletedNCT00698568Phase 3
- Humoral and Cellular Immune Response of Herpes Simplex (gD) Candidate Vaccines From 2 Different Cell LinesCompletedNCT00698490Phase 1/2
- Evaluation of Immunogenicity, Reactogenicity and Safety of Herpes Simplex (gD) Candidate Vaccine With/Without AdjuvantCompletedNCT00697567Phase 2
- Valacyclovir Suppression to Improve the Stability of Vaginal Flora Among HSV-2 Seropositive WomenWithdrawnNCT00682721Not applicable
- HerpeSelect® Express Rapid Test Study Protocol: Sexually Active Adult PopulationCompletedNCT00655434
- Study to Compare Efficacy of Topical ARYS-01 (Sorivudine) Cream 3%, Oral Valaciclovir and Combination ARYS-01 Cream 3%/Oral Valaciclovir for Treatment of Herpes Zoster (Shingles)Status unknownNCT00652184Phase 2
- Activation of Alternative Cellular Energy (ACE) Pathway in the Therapy of Herpes Virus InfectionsCompletedNCT00642785
- 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of VolunteersStatus unknownNCT00587496Phase 1
- Measuring Herpes Zoster and PHN Associated Burden of Illness and Health Care Utilization Costs in ThailandCompletedNCT00526864
- VZV PCR Sampling Validation StudyCompletedNCT00501670
- Dose-finding Study of ASP2151 in Subjects With Herpes ZosterCompletedNCT00487682Phase 2
- A Study With ASP2151 in Subjects With Recurrent Episodes of Genital HerpesCompletedNCT00486200Phase 2
- Iontophoretic Application of Acyclovir Gel to Treat Cold SoresCompletedNCT00469300Phase 2
- Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis)Status unknownNCT00467662Phase 4
- HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsCompletedNCT00465205Phase 3
- Safety, Pharmacokinetics, and Efficacy Study of NB-001 to Treat Recurrent Herpes LabialisCompletedNCT00453401Phase 2
- HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1, HSV-2 Co-infected Men.CompletedNCT00378976Phase 3
- Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in AdolescentsCompletedNCT00375570Phase 3
- Effectiveness of Acyclovir in Suppressing HIV Viral Load in Women Coinfected With HIV and Herpes Simplex Virus Type 2 (HSV-2)CompletedNCT00371592Phase 2
- Efficacy and Safety Study of ME-609 and Acyclovir for Treatment of Herpes Simplex LabialisCompletedNCT00361881Phase 3
- The Efficacy of Two Potential Diagnostic Assays for Herpes Simplex Keratitis (HSK)CompletedNCT00357812
- VivaGel™ in Healthy Young WomenCompletedNCT00331032Phase 1
- Evolution of Pain From Herpes ZosterCompletedNCT00305357
- A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And ChildrenCompletedNCT00297206Phase 1
- Valacyclovir+Temovate Gel for the Treatment of Herpes LabialisCompletedNCT00297011Phase 2
- A Study to Evaluate the Safety and Efficacy of Single Day or Single Dose Famciclovir for the Treatment of Recurrent Herpes LabialisCompletedNCT00248144Phase 4
- Iontophoretic Application of Acyclovir Cream to Treat Recurrent Herpes LabialisCompletedNCT00230867Phase 2
- Study to Compare Safety and Immunogenicity of Commercial Scale Consistency Lots of Herpes Simplex VaccineCompletedNCT00224471Phase 3
- RELIEF: Randomized Episodic Versus Long-Term Suppression Experience With FamciclovirCompletedNCT00219310Phase 4
- Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible MicrobicideCompletedNCT00213031Phase 2
- Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV TransmissionCompletedNCT00194519Phase 3
- A Study of HSV Testing Among Pregnant WomenTerminatedNCT00194415Not applicable
- Efficacy and Safety of Oral Famciclovir in Patients With Active Recurrent Genital HerpesCompletedNCT00171990Phase 3
- Episodic Acyclovir Therapy for Genital UlcersCompletedNCT00164424Phase 2/3
- A Study of Valacyclovir to Suppress HSV and HIV Shedding in Coinfected PersonsCompletedNCT00161434Phase 4
- Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV SheddingCompletedNCT00158509Phase 2
- Anti-Herpetic Treatment of Genital Ulcer : Effect on HIV & Herpes Shedding (ANRS 1212)CompletedNCT00158483Phase 2
- Herpevac Neonatal SubstudyTerminatedNCT00138320
- A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus SheddingCompletedNCT00129818Phase 4
- A Clinical Research Study For The Suppression And Treatment Of Genital Herpes Infection In HIV-Infected PersonsTerminatedNCT00079911Phase 4
- HIV and Genital Herpes Among High-Risk Men Who Have Sex With Men (MSM) in Lima, PeruCompletedNCT00023582
- Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and MouthCompletedNCT00006135Phase 3
- Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Involving the Central Nervous SystemStatus unknownNCT00006132Phase 3
- A Study of Valacyclovir as Treatment for Genital Herpes Simplex Virus in HIV-Infected PatientsStatus unknownNCT00005663Phase 3
- Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and MouthCompletedNCT00004757Phase 3
- Phase I/II Study of High-Dose Acyclovir for Central Nervous System or Disseminated Neonatal Herpes Simplex Virus InfectionCompletedNCT00004644Phase 1/2
- The Effect of Valacyclovir on the Detection of HIV From Genital Herpes Lesions in HIV-Infected PatientsCompletedNCT00002404Not applicable
- SP-303T Applied to the Skin of Patients With Herpes Simplex Virus (HSV) Infection and AIDS Who Have Not Had Success With AcyclovirCompletedNCT00002310Not applicable
- An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other ImmunodeficienciesCompletedNCT00002272Not applicable
- Double-Blind Placebo-Controlled Study Comparing the Combination of 15% SP-303 Gel With Acyclovir Versus Acyclovir Alone for the Treatment of Recurrent Herpes Simplex Virus (HSV) Infections in Subjects With Acquired Immunodeficiency Syndrome (AIDS)CompletedNCT00002186Not applicable
- Cidofovir as a Treatment for Herpes Simplex in Patients With AIDSCompletedNCT00002181Not applicable
- The Pilot Study of Foscarnet Cream in the Treatment of Mucocutaneous Herpes Simplex Virus Infections in Immunocompromised Patients Unresponsive to Acyclovir TreatmentCompletedNCT00002144Phase 1
- A Phase I/II Study of the Safety and Efficacy of Topical 1-(S)-(3-Hydroxy-2-Phosphonylmethoxypropyl)Cytosine Dihydrate (Cidofovir; HPMPC) in the Treatment of Refractory Mucocutaneous Herpes Simplex Disease in Patients With AIDSCompletedNCT00002116Phase 1
- A Comparative Trial of Valacyclovir Hydrochloride ( 256U87 ) and Acyclovir for the Suppression of Anogenital Herpes Infections in HIV-Infected PatientsCompletedNCT00002084Not applicable
- An Open Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other ImmunodeficienciesCompletedNCT00002021Not applicable
- A Study to Compare the Efficacy and Safety of Valacyclovir Hydrochloride ( 256U87 ) Versus Acyclovir in the Treatment of Recurrent Anogenital Herpes Infections in HIV Infected PatientsCompletedNCT00002000Not applicable
- Valaciclovir to Prevent Transmission of Herpes Simplex VirusCompletedNCT00001649Phase 3
- Structure of the Herpes Simplex Virus ReceptorCompletedNCT00001648
- The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the BloodCompletedNCT00001115Not applicable
- The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected ChildrenWithdrawnNCT00001054Phase 1
- Comparison of Foscarnet Versus Vidarabine in the Treatment of Herpes Infection in Patients With AIDS Who Have Not Had Success With AcyclovirCompletedNCT00000985Phase 3
- The Tolerance of HIV-Infected Patients With Herpes Group Virus Infections to Oral Doses of FIAUCompletedNCT00000654Phase 2
- Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients With AIDS: Open Label Pilot Study of Topical TrifluridineCompletedNCT00000635Not applicable